200
Participants
Start Date
December 1, 2023
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2026
BCG vaccine (two doses, 4 weeks apart)
BCG vaccine provided intradermally at the upper arm.
Saline placebo (Two doses, 4 weeks apart)
Participants randomized to the control group (placebo) will receive one 0.1 ml dose sterile 0.9 % NaCl by intradermal injection in the left deltoid region.
RECRUITING
Bandim Health Project, Bissau
University of Coimbra
OTHER
Steno Diabetes Center Copenhagen
OTHER
University of Southern Denmark
OTHER
Sydvestjysk Sygehus
UNKNOWN
Bandim Health Project
OTHER